Value of Pharmaceuticals in Managed Care Pharmacy

Slides:



Advertisements
Similar presentations
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Advertisements

November 26, Fall Forum Alberta’s Pharmaceutical Strategy and Programs Policy Recommendations.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
The Facts About Rising Health Care Costs.
PPF- Atlantic Summit on Healthcare and Drug Cost Sustainability Perry Eisenschmid CEO, Canadian Pharmacists Association October 30, 2014.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Universal- Multi Payer PowerPoint Universal Means for Everyone! It’s the promise of this grant. Michicare? Better for people: better for business.
The Economic and Health Effects of Biomedical Innovation Peter R. Orszag Vice Chairman, Corporate and Investment Banking Chairman, Financial Strategy and.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
1 South Carolina Medicaid Coordinated Care and Enrollment Counselors Programs.
HSCI 678 Intro to US Healthcare System Biomedical Research, Technology, and Assessment Chapter 10 Dr. Tracey Lynn Koehlmoos.
MEDICAL INNOVATION March What Are The Public Health Benefits of Medical Innovation? Breakthrough medicines New devices Innovative medical procedures.
Insurope 24th General Meeting Stockholm 2004 Consumer Directed Healthcare The Next American Revolution The Next American Revolution.
Benefits Open Enrollment May 7-27, 2014 Health Care Enterprises - HCE.
Mohammad Aljawadi PharmD, PhD Clinical Pharmacy Department King Saud University PHCL 431 Sep, 2015.
How Much Would A Medicare Prescription Drug Benefit Cost? Offsets in Medicare Part A Cost by Increased Drug Use Zhou Yang, Ph.D. Assistant Professor Department.
Vermont Blueprint for Health Sharon Moffatt Commissioner of Health August 2007.
Improving Value in Health Care: Challenges and Potential Strategies Arnold M Epstein October 24, 2008 Congressional Health Care Reform Education Project.
1 SWITCH Individual and public health benefits October 2015.
Drug Formulary Development & Management
Presentation Developed for the Academy of Managed Care Pharmacy
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
PREVENTION PLUS Brought to you by:. As of January 1, 2015, CMS has started paying MONTHLY reimbursement for care coordination services to eligible Medicare.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Pharmacy & Therapeutics Committee Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2016.
1.03 Healthcare Finances.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Medication therapy management
Wireless Access SSID: cwag2017
Lesson 6-2 Protecting Income
Pharmacy & Therapeutics Committee
Us Healthcare System.
HEALTH ECONOMICS BASICS
1.03 Healthcare Finances.
Presentation Developed for the Academy of Managed Care Pharmacy
National Health Reform is Essential
Cindy Hatton President & CEO Susan Levitt V.P. Clinical Services/COO
The Path to Provider Status
Chapter 6: Social Work in Health Care
Clinical Pharmacy II.
Integrating Clinical Pharmacy into a wider health economy
Value of Pharmaceuticals in Managed Care Pharmacy
Pharmacy & Therapeutics Committee
Set the Stage (2-3 Slides)
Value of Pharmaceuticals in Managed Care Pharmacy
1.03 Healthcare Finances.
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Presentation Developed for the Academy of Managed Care Pharmacy
New Opportunities in Medicare
Prior authorization and patient cost-sharing are least likely to be seen as effective in reducing unnecessary care. “How effective do you think each of.
1.03 Healthcare Finances.
Provider and Member Education in Managed Care Pharmacy
The Edward Jenner Programme Challenges in Healthcare
Chronic Disease Challenges & Opportunities for Improvement
1.03 Healthcare Finances.
Essential to the Future of South African Healthcare
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Health Insurance: The Basics
1.03 Healthcare Finances.
Pharmacy & Therapeutics Committee
Epidemiological Terms
Component 1: Introduction to Health Care and Public Health in the U.S.
1.03 Healthcare Finances.
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Drug Formulary Development & Management
Presentation Developed for the Academy of Managed Care Pharmacy
Pharmacy & Therapeutics Committee
Value of Pharmaceuticals in Managed Care Pharmacy
Presentation Developed for the Academy of Managed Care Pharmacy
Presentation transcript:

Value of Pharmaceuticals in Managed Care Pharmacy Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2016

What is Managed Care Pharmacy? The practice of designing and implementing drug benefits for the more than 270 million Americans covered by public or private health insurance Managed care pharmacy focuses on: Developing drug benefits and utilization programs that promote medication use that improves patient wellbeing while reducing total cost of care

The Value Equation in Pharmaceuticals Evidence-based treatments that increase the likelihood of achieving desired health outcomes Usually defined as drug cost, and as applicable administration and adverse effect costs Quality Cost VALUE = If quality increases, and cost decreases, value of the pharmaceutical is increased substantially If quality remains constant, and cost increases, the value decreases If quality increases, and cost remains constant, the value increases How do we put a value on pharmaceuticals? What are the variables to be considered? The two variables are quality and cost. The dynamic between these two variables is what determines value.

Pharmaceuticals in the Total Healthcare Process The value of pharmaceuticals is also taken into consideration for the total healthcare delivery process Three options for treatment of disease Lifestyle changes Pharmaceuticals Surgical /Invasive intervention Least invasive, usually considered first, when appropriate Considering a choice between a pharmaceutical regimen or surgical /invasive procedure, most will choose a pharmaceutical regimen

Value of Pharmaceuticals Pharmaceuticals help people to manage their illnesses and live full, productive lives Pharmaceuticals may save money by preventing expensive hospital treatments and other therapies Today’s medicines fund research and development for tomorrow’s prescription drug innovations The FDA approved 39 novel drugs in 2014 So, we’ve talked about how medicines can help people manage their illness and lead longer lives, but now let’s look at how medicines can save money by preventing the need for other more expensive services like hospital stays and emergency room visits. Now I know that many people believe that medicines cost too much, but let’s look at what you get for your money in addition to improved health and wellness or treating your illness. NOV-800268 10/5/07

Value of Pharmaceuticals New Medicines Account for 40% of Increase in Life Expectancy – 1988-2000 NCE = New Chemical Entity = new drugs The gold bar on this chart shows the increase in longevity in our life spans from 1988 to 2000. In just 12 years, our life expectancy has increased approximately two years!! There are lots of reasons we are living longer – we eat healthier, drive safer cars, and other things. But new medications account for almost a year of the two years we’ve added. Medicines, simply put, often allow us to live longer by treating serious, life-threatening illnesses such as cancer, and allow us to better manage chronic conditions such as heart disease and diabetes. NOV-800268 10/5/07 Source: FR Lichtenberg, “The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001,” (Cambridge, Mass., National Bureau of Economic Research: June 2003).

Value of Pharmaceuticals Medical innovation (i.e., newer drugs) accounted for a greater portion (60%) of the increase in life expectancy between 1991-2004 Of the 3.88-year increase in life expectancy at birth, use of newer drugs accounted for 2.43 years (63%) Of the 2.15-year increase in life expectancy at age 65, use of newer drugs accounted for 1.19 years (55%) Analysis was based on drug vintage, or year that the drug was approved by the FDA. The author found that, some obvious suspects—obesity, smoking, and the incidence of HIV/AIDS—played a role, but the most important factor was access to newer drugs, as measured by mean “vintage” (FDA approval year). Study was conducted using Medicare & Medicaid data. Lictenberg F. “Why Has Longevity Increased More in Some States than in Others? The Role of Medical Innovation and Other Factors,” Manhattan Institute for Policy Research. Medical Progress Report No 4, July 2007.

Value of Pharmaceuticals Reductions in Disease Attributed Deaths Diseases that were once fatal can now be treated with medication, which has resulted in dramatic decreases in death rates. When you look at this list, you probably know people who have or have had these problems. Without medication, their lives may be very different. NOV-800268 10/5/07 EFPIA 1999-2002.

Value of Pharmaceuticals Diabetes Costs Reduced Through Improved Glycemic Control No single illness results in as many direct and indirect costs to the healthcare system as diabetes. This study shows the impact on these costs through use of medicines to improve glycemic control. The results show a nearly 30% reduction in costs after three years of treatment. The savings are even greater after four years. And most importantly, the reduction in complications improves the quality of life. NOV-800268 10/5/07 Source: E.H. Wagner, et al., “Effect of Improved Glycemic Control on Health Care Costs and Utilization,” Journal of the American Medical Association, 285 (2001): 2, 182-189.

Value of Pharmaceuticals Summary : The managed care pharmacist is well equipped to help purchasers, payers, providers and patients understand the overall value of pharmaceuticals

Thank you to AMCP member Carrie McAdam-Marx for updating this presentation for 2016.